Download: Planning a clinical development program for biosimilars that meets the registration requirements of multiple regions

HN

Download this presentation here >

The World Biosimilar Congress  brings together pharma, biotech, academia and regulators and the wider service provider community to discuss the latest R&D, process, production, regulation and to-market strategies for biosimilar medicines.

At the 2013 event, delegates were fortunate enough to hear from Hideaki Nomura, President and CEO, Fujifilm Kyowa Kirin Biologics Co Ltd, who delivered the presentation ‘Planning a clinical development program for biosimilars that meets the registration requirements of multiple regions‘.

Download this presentation here >

If you’re interested in in learning more and engaging in discussion on biosimilar medicines, you might want to check out the World Biosimilar Congress 2014 – preparations are in full swing! Make sure you’re keeping up to date on the latest developments in this exciting market.

Leave a Reply

Your email address will not be published. Required fields are marked *